These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 38457412

  • 1. Novel insights into RAGE signaling pathways during the progression of amyotrophic lateral sclerosis in RAGE-deficient SOD1 G93A mice.
    Nowicka N, Zglejc-Waszak K, Juranek J, Korytko A, Wąsowicz K, Chmielewska-Krzesińska M, Wojtkiewicz J.
    PLoS One; 2024; 19(3):e0299567. PubMed ID: 38457412
    [Abstract] [Full Text] [Related]

  • 2. The Involvement of RAGE and Its Ligands during Progression of ALS in SOD1 G93A Transgenic Mice.
    Nowicka N, Szymańska K, Juranek J, Zglejc-Waszak K, Korytko A, Załęcki M, Chmielewska-Krzesińska M, Wąsowicz K, Wojtkiewicz J.
    Int J Mol Sci; 2022 Feb 16; 23(4):. PubMed ID: 35216298
    [Abstract] [Full Text] [Related]

  • 3. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1G93A murine model of amyotrophic lateral sclerosis in a sex-dependent manner.
    MacLean M, Juranek J, Cuddapah S, López-Díez R, Ruiz HH, Hu J, Frye L, Li H, Gugger PF, Schmidt AM.
    J Neuroinflammation; 2021 Jun 15; 18(1):139. PubMed ID: 34130712
    [Abstract] [Full Text] [Related]

  • 4. Absence of Receptor for Advanced Glycation End Product (RAGE) Reduces Inflammation and Extends Survival in the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis.
    Lee JD, McDonald TS, Fung JNT, Woodruff TM.
    Mol Neurobiol; 2020 Oct 15; 57(10):4143-4155. PubMed ID: 32676989
    [Abstract] [Full Text] [Related]

  • 5. Effects of RAGE inhibition on the progression of the disease in hSOD1G93A ALS mice.
    Liu L, Killoy KM, Vargas MR, Yamamoto Y, Pehar M.
    Pharmacol Res Perspect; 2020 Aug 15; 8(4):e00636. PubMed ID: 32776498
    [Abstract] [Full Text] [Related]

  • 6. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Ringer C, Büning LS, Schäfer MK, Eiden LE, Weihe E, Schütz B.
    Neurobiol Dis; 2013 Jun 15; 54():32-42. PubMed ID: 23466699
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Lee JD, Liu N, Levin SC, Ottosson L, Andersson U, Harris HE, Woodruff TM.
    J Neuroinflammation; 2019 Feb 19; 16(1):45. PubMed ID: 30782181
    [Abstract] [Full Text] [Related]

  • 8. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1G93A ) mouse model of amyotrophic lateral sclerosis include sex-dependent phenotypes.
    Kreilaus F, Guerra S, Masanetz R, Menne V, Yerbury J, Karl T.
    Genes Brain Behav; 2020 Feb 19; 19(2):e12604. PubMed ID: 31412164
    [Abstract] [Full Text] [Related]

  • 9. Exercise, disease state and sex influence the beneficial effects of Fn14-depletion on survival and muscle pathology in the SOD1G93A amyotrophic lateral sclerosis (ALS) mouse model.
    Hazell G, McCallion E, Ahlskog N, Sutton ER, Okoh M, Shaqoura EIH, Hoolachan JM, Scaife T, Iqbal S, Bhomra A, Kordala AJ, Scamps F, Raoul C, Wood MJA, Bowerman M.
    Skelet Muscle; 2024 Oct 14; 14(1):23. PubMed ID: 39396990
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological inhibition of ALCAT1 mitigates amyotrophic lateral sclerosis by attenuating SOD1 protein aggregation.
    Liu X, Zhang J, Li J, Song C, Shi Y.
    Mol Metab; 2022 Sep 14; 63():101536. PubMed ID: 35772643
    [Abstract] [Full Text] [Related]

  • 11. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM, Smit-Oistad IM, Macrander C, Krakora D, Meyer MG, Suzuki M.
    Exp Neurol; 2016 Mar 14; 277():275-282. PubMed ID: 26775178
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX, Mok SS, Laughton KM, McLean CA, Volitakis I, Cherny RA, Cheung NS, White AR, Masters CL.
    Aging Cell; 2006 Apr 14; 5(2):153-65. PubMed ID: 16626394
    [Abstract] [Full Text] [Related]

  • 13. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
    Vallarola A, Sironi F, Tortarolo M, Gatto N, De Gioia R, Pasetto L, De Paola M, Mariani A, Ghosh S, Watson R, Kalmes A, Bonetto V, Bendotti C.
    J Neuroinflammation; 2018 Mar 01; 15(1):65. PubMed ID: 29495962
    [Abstract] [Full Text] [Related]

  • 14. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M, Giribaldi F, Melone M, Bonifacino T, Musante I, Carminati E, Rossi PI, Vergani L, Voci A, Conti F, Puliti A, Bonanno G.
    Neurobiol Dis; 2014 Apr 01; 64():48-59. PubMed ID: 24361555
    [Abstract] [Full Text] [Related]

  • 15. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Bonifacino T, Provenzano F, Gallia E, Ravera S, Torazza C, Bossi S, Ferrando S, Puliti A, Van Den Bosch L, Bonanno G, Milanese M.
    Neurobiol Dis; 2019 Sep 01; 129():79-92. PubMed ID: 31102766
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic Treatment of Superoxide Dismutase 1 (G93A) Amyotrophic Lateral Sclerosis Model Mice with Medical Ozone Decelerates Trigeminal Motor Neuron Degeneration, Attenuates Microglial Proliferation, and Preserves Monocyte Levels in Mesenteric Lymph Nodes.
    Bette M, Cors E, Kresse C, Schütz B.
    Int J Mol Sci; 2022 Mar 21; 23(6):. PubMed ID: 35328829
    [Abstract] [Full Text] [Related]

  • 17. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis.
    Zhang Y, Ogbu D, Garrett S, Xia Y, Sun J.
    Gut Microbes; 2021 Mar 21; 13(1):1996848. PubMed ID: 34812107
    [Abstract] [Full Text] [Related]

  • 18. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Apolloni S, Amadio S, Montilli C, Volonté C, D'Ambrosi N.
    Hum Mol Genet; 2013 Oct 15; 22(20):4102-16. PubMed ID: 23736299
    [Abstract] [Full Text] [Related]

  • 19. Cdk5 inhibition in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis suppresses neurodegeneration and extends survival.
    Kim A, Lee DY, Sung JJ.
    J Neurochem; 2024 Sep 15; 168(9):2908-2925. PubMed ID: 38934222
    [Abstract] [Full Text] [Related]

  • 20. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.
    Turner BJ, Ackerley S, Davies KE, Talbot K.
    Hum Mol Genet; 2010 Mar 01; 19(5):815-24. PubMed ID: 20008901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.